Skip to main content

The Jackson Laboratory

  • Home
    • Autoimmune/Inflammation
    • Essentials
    • Immunology
    • Immuno-oncology/Oncology
    • Infectious Disease
    • Metabolic
    • Neurobiology
    • Rare Disease
    • Blog
    • Case Studies
    • Clinical Education Online Courses
    • eBooks
    • Fact Sheets
    • Guides
    • Livestream Videos
    • JAX Tech Talks
    • On-Demand Videos
    • Online MiniCourses
    • Portfolios
    • White Papers

Recent Searches

    Share this Post

    • Share on facebook
    • Share on twitter
    • Share on linkedin
    • Share on email
    1. Home
    2. Clinical Education Online Courses
    3. Indications for Germline Testing after Genomic Tumor Testing (CME/CNE)

    Indications for Germline Testing after Genomic Tumor Testing (CME/CNE)

    Self-paced • 0.5 credits

    About this course

    The goal of genomic tumor testing is to identify biomarkers that have predictive (therapeutic) or prognostic significance for an active cancer. Some of the DNA variants detected through these tests that are relevant for therapeutic decisions can also be associated with hereditary cancer risks (e.g., BRCA1, BRCA2). Knowing when a hereditary variant is present can be helpful in identifying targeted treatments, informing about future cancer risks, and identifying when close relatives might be at risk. This module will help you interpret genomic tumor test results to determine when a patient should be further evaluated for hereditary (germline) risk. This module uses practice cases to facilitate learning-by-doing, discussion of in-depth topics, and additional resources for more detail.

     

    ACCESS CME   ACCESS CNE

     

    Learning Objectives

    Upon completion of this educational activity, the learner will be able to:

    • Determine when germline testing may be indicated 
    • Recognize steps and resources to facilitate germline testing 

     

    Target Audience

    Oncologists and other cancer clinicians, including fellows, physician assistants and nurses.

     

    Disclaimer

    All information in Precision Oncology Online Education is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Precision Oncology Online Education. Reliance on any information in Precision Oncology Online Education is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Precision Oncology Online Education.

     

    Sign up for this course today!

    ACCESS CME   ACCESS CNE
     
    • Previous Article

      Choosing the Best Genomic Tumor Test (CME/CNE)

      Choosing the Best Genomic Tumor Test (CME/CNE)

      Learn about the benefits and limitations of different genomic tumor test options for patients with cancer and how to determine the best test for each patient.

    • Next Article

      Hereditary cancer syndromes: Are your patients at risk? (CME/CNE)

      Hereditary cancer syndromes: Are your patients at risk? (CME/CNE)

      Develop skills and knowledge to identify those patients most appropriate for genetic testing, choosing the right test, and using the results to develop a management plan.

    Other content in this Stream

    • Choosing the Best Genomic Tumor Test (CME/CNE)

      Choosing the Best Genomic Tumor Test (CME/CNE)

      Learn about the benefits and limitations of different genomic tumor test options for patients with cancer and how to determine the best test for each patient.

      Learn More

    • Hereditary cancer syndromes: Are your patients at risk? (CME/CNE)

      Hereditary cancer syndromes: Are your patients at risk? (CME/CNE)

      Develop skills and knowledge to identify those patients most appropriate for genetic testing, choosing the right test, and using the results to develop a management plan.

      Learn More

    • Collecting Family History with Sufficient Detail (CME)

      Collecting Family History with Sufficient Detail (CME)

      Learn More

    • Collecting Family History with Sufficient Detail (CNE)

      Collecting Family History with Sufficient Detail (CNE)

      Learn More

    • Identifying Red Flags and Patterns that Increase Cancer Risk (CME)

      Identifying Red Flags and Patterns that Increase Cancer Risk (CME)

      Learn More

    • Identifying Red Flags and Patterns that Increase Cancer Risk (CNE)

      Identifying Red Flags and Patterns that Increase Cancer Risk (CNE)

      Learn More

    • Categorizing Cancer Risk (CME)

      Categorizing Cancer Risk (CME)

      Learn More

    • Categorizing Cancer Risk (CNE)

      Categorizing Cancer Risk (CNE)

      Learn More

    • Using Family History to Inform Management (CME)

      Using Family History to Inform Management (CME)

      Learn More

    • Using Family History to Inform Management (CNE)

      Using Family History to Inform Management (CNE)

      Learn More

    • Cancer Genetic Testing Process (CME)

      Cancer Genetic Testing Process (CME)

      Learn More

    • Cancer Genetic Testing Process (CNE)

      Cancer Genetic Testing Process (CNE)

      Learn More

    • Cancer Pretest Decisions & Counseling (CME)

      Cancer Pretest Decisions & Counseling (CME)

      Learn More

    • Cancer Pretest Decisions & Counseling (CNE)

      Cancer Pretest Decisions & Counseling (CNE)

      Learn More

    • Interpreting Cancer Genetic Testing Results (CME)

      Interpreting Cancer Genetic Testing Results (CME)

      Learn More

    • Interpreting Cancer Genetic Testing Results (CNE)

      Interpreting Cancer Genetic Testing Results (CNE)

      Learn More

    • Genetic Testing for Breast Cancer Risk (CME)

      Genetic Testing for Breast Cancer Risk (CME)

      Learn More

    • Genetic Testing for Breast Cancer Risk (CNE)

      Genetic Testing for Breast Cancer Risk (CNE)

      Learn More

    • Genetic Testing for Colorectal Cancer Risk (CME)

      Genetic Testing for Colorectal Cancer Risk (CME)

      Learn More

    • Genetic Testing for Colorectal Cancer Risk (CNE)

      Genetic Testing for Colorectal Cancer Risk (CNE)

      Learn More

    Return to Home
    © The Jackson Laboratory